RxDoctor Payments DataLook up a doctor →

Elan Diamond, MD

Hematology & Oncology · Bloomfield, NJNPI 1659530608

Payments from drug & device makers

$401,390in general payments, 2019–2025

Across 226 payments — averaging $1776.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$235K
  • Merck$85K
  • Astrazeneca UK Limited$18K
  • QED Therapeutics, Inc.$9K
  • AstraZeneca$9K
  • Ferring International Pharmascience Center US$8K
  • plus $38K from 16 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$401,390 in reported general payments places this provider in the 90th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey

Medicare billing

Part B allowed, 2024
$4,018,703
Medicare patients
540
Services billed
98,751

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Bloomfield

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →